|
|
Article: Geron Granted European Patent Covering Nuclear Transfer Technology.
- Article from:
- Business Wire
- Article date:
- February 6, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
MENLO PARK, Calif.--(BW HealthWire)--Feb. 6, 2002
Geron Corp. (Nasdaq:GERN) announced today that the European Patent Office has granted European Patent No. 0849990 including 21 claims covering various aspects of the use of nuclear transfer technology in the cloning of non-human animals.
"We're pleased that our nuclear transfer patent portfolio is maturing and that the pioneering nature of this technology is being recognized by the granting of patents around the world," noted David J. Earp, J.D., Ph.D., Geron's vice president of intellectual property. "The claims of this European patent cover the cloning ...